Roche's Response to COVID-19
Our singular focus remains: We are bringing our medical and scientific expertise to the fight against COVID-19.
Separates RNA from other materials in sample prior to downstream testing (LDTs).
Detects SARS-CoV-2 in currently infected patients with high sensitivity.
Detects a patient’s immune response to SARS CoV-2 with high specificity.
Clinical Decision Support
Biomarkers that provide valuable information to aid in the management of COVID-19 patients.